DAP
Disease Assessment and Management
Friday, June 1, 2018: 2:00 PM-4:00 PM
104 C-E (Nashville Music City Center)
2:15 PM
Optimal Inter-Eye Difference Thresholds in Retinal Nerve Fiber Layer and Ganglion Cell Layer Thickness for Predicting a Unilateral Optic Nerve Lesion in Multiple Sclerosis
Rachel Nolan, BA, NYU Langone Medical Center;
Omar Akhand, BS, NYU School of Medicine;
Peter A Calabresi, MD, Johns Hopkins University;
Friedemann Paul, MD, Charité-Universitätsmedizin Berlin;
Elena Hernandez Martinez de Lapiscina, MD, PhD, Hospital Clínic de Barcelona;
Axel Petzold, MD, PhD, UCL Institute of Neurology;
Alexander Brandt, MD, Charité - Universitätsmedizin Berlin;
Shiv Saidha, MBBCh, Johns Hopkins University;
Pablo Villoslada, MD, Institut d'Investigacions Biomèdiques August Pi i Sunyer;
Abdullah Abu Al-Hassan, MD, Dasman Institute;
Raed Behbehani, MD, Dasman Institute;
Elliot Frohman, MD, PhD, FAAN, UT Southwestern Medical Center;
Teresa Frohman, MPAS, PA-C, University of Texas Southwestern;
Joachim Havla, MD, Ludwig-Maximilians-University of Munich;
Bernhard Hemmer, MD, PhD, Munich Cluster for Systems Neurology (SyNergy);
Hong Jiang, MD, PhD, Bascom Palmer Institute;
Benjamin Knier, MD, Technische Universität München;
Thomas Korn, MD, Technische Universität München;
Letizia Leocani, MD, Ospedale San Raffaele;
Athina Papadopoulou, MD, University of Basel;
Marco Pisa, MD, Ospedale San Raffaele;
Hanna Zimmermann, M.Eng, Charité - Universitätsmedizin Berlin;
Steven Galetta, MD, New York University Langone Medical Center;
Laura J Balcer, MD, MSCE, New York University Langone Medical Center
2:30 PM
Rationale and Design of the Traditional Versus Early Aggressive Therapy for MS (TREAT-MS) Trial
Scott D. Newsome, DO, Johns Hopkins University School of Medicine;
Thomas J Shoemaker, MD, Johns Hopkins University School of Medicine;
Sandra D Cassard, ScD, Johns Hopkins University School of Medicine;
Elizabeth Ogburn, PhD, Johns Hopkins School of Public Health;
Jerry Prince, PhD, Johns Hopkins University;
Ellen M Mowry, MD, MCR, Johns Hopkins School of Medicine
2:45 PM
Derivation and Validation of a Predictive Model for 30-Day Readmission Risk in Patients with Multiple Sclerosis
Kanika Sharma, MD, University of Iowa;
Yubo Gao, PhD, University of Iowa;
Junlin Liao, PhD, University of Iowa;
John A Kamholz, MD, PhD, University of Iowa;
Frank R Bittner, DO, University of Iowa;
Piyush Kalakoti, MD, University of Iowa
3:15 PM
The North American Registry for Care and Research in Multiple Sclerosis
Kottil Rammohan, MD, University of Miami;
Anne Cross, MD, Washington University in St. Louis;
David E Jones, MD, UVA;
June Halper, MSN, ANP, FAAN, CEO-CMSC;
Sara McCurdy Murphy, BA, Social & Scientific Systems, Inc.;
Lisa Patton, BA, Social & Scientific Systems, Inc.;
Edward J. Fox, MD, PhD, Central Texas Neurology Consultants;
Lori Mayer, DNP, MSN, RN, MSCN, Central Texas Neurology Consultants,;
Michael K Racke, MD, Wexner Medical Center, Ohio State University
3:30 PM
Obesity at Onset Impacts the Early Clinical Presentation of Multiple Sclerosis
Farren B.S. Briggs, Ph.D. Sc.M., Case Western Reserve University;
Justin Yu, MS(c) BS, Case Western Reserve University;
Jinghong Jiangyang, MS(c) B.S., Case Western Reserve University;
Erica Utigard, DO, The Cleveland Clinic;
Douglas D. Gunzler, Ph.D., Case Western Reserve University;
Daniel Ontaneda, MD, Cleveland Clinic
3:45 PM
Pediatric-Onset Multiple Sclerosis Is Associated with Reduced Parental Health-Related Quality of Life and Family Functioning
Julia O'Mahony, BSc, Hospital for Sick Children;
Ruth Ann Marrie, MD, PhD, University of Manitoba;
Amit Bar-Or, MD, University of Pennsylvania;
E Ann Yeh, MD, Hospital for Sick Children;
Brenda Banwell, MD, Children's Hospital of Philadelphia